File Name,Company Name
Zehna Corporate Deck SymBiosis,"Action Compound Name
Angiotensin"
PS_TCRR_NOTE_1.5.23,Piper Sandler Ltd.
Grace Sciece Platform (9.2.20),Grace Science
AcuamarkDx Series A_Corp Deck,AcuamarkDx Inc
coding.bio_deck,"CAR
Novel-CARNovel in House CARs"
Centurion_BioPharma-Non-Confidential_2021_2,Centurion BioPharma Corporation
JPM_SRZN_NOTE_11.28.22,JPMorgan Chase & Co
G_ACET_IOC_4.8.21,GUGGENHEIM SECURITIES
C_ARQT_NOTE_11.15.22,Therapeutics Conference
B_RXRX_IOC_9.21.21,RXRX
Dianomi Non-Confidential Slides - v3,DianomiTherapeutics
KBC_MAAT.FR_IOC_12.14.21,Seres Therapeutics
Engrail Therapeutics,CONFIDENTIAL
WB_VOR_IOC_1.25.22,Wedbush Securities
E_FNCH_IOC_8.10.21,Genome & Company
CG_GRNA_IOC_12.8.22,GreenLight Biosciences Holdings
LT_AVXL_NOTE_6.22.21,Ladenburg Thalmann & Co. Inc
LT_PHGE_IOC_4.15.21,Yeda
Graviton Corporate Presentation July 2022,ROCK2
Bectas Tx Non-Con - Aug.1.2022,ealth LLC
20 080822_PRTA_Research Summary,"Company 2.68 5.43%
BlackRock Institutional Trust Company"
CT one-pager Dec 22,Tasimelteon
221003_PRE_Numab Non-Confidential Presentation,PROGRAM FOCUS
2022-3-18 Apeximmune non-confidential Baird,Immunology
Alto Overview_April 2022,NGONITITINEGGROACT
[NON-NDA] Integral Overview,DisclaimerIntegral
JMP_NXTC_IOC_5.26.20,NextCure
Flare Non-Con Deck November 2022,Nature Chemical Biology
AscelpiX Corporate Presentation NON CONFIDENTIAL Feb 8 2022,AXT107AXT107
